Article
Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals
2022-05-11
Abstract excerpt
The binding of the SARS-CoV-2 spike to angiotensin-converting enzyme 2 (ACE2) promotes virus entry into the cell. Targeting this interaction represents a promising strategy to generate antivirals. By screening a phage-display library of biosynthetic protein sequences build on a rigid alpha-helicoidal HEAT-like scaffold (named αReps), we selected candidates recognizing the spike receptor binding domain (RBD). Two o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- faf14c91-f561-5802-bd3d-a724025044a3
- DOI
- 10.1101/2022.05.10.491295
